» Articles » PMID: 21282433

Effect of Antibiotic Treatment on the Intestinal Metabolome

Overview
Specialty Pharmacology
Date 2011 Feb 2
PMID 21282433
Citations 130
Authors
Affiliations
Soon will be listed here.
Abstract

The importance of the mammalian intestinal microbiota to human health has been intensely studied over the past few years. It is now clear that the interactions between human hosts and their associated microbial communities need to be characterized in molecular detail if we are to truly understand human physiology. Additionally, the study of such host-microbe interactions is likely to provide us with new strategies to manipulate these complex systems to maintain or restore homeostasis in order to prevent or cure pathological states. Here, we describe the use of high-throughput metabolomics to shed light on the interactions between the intestinal microbiota and the host. We show that antibiotic treatment disrupts intestinal homeostasis and has a profound impact on the intestinal metabolome, affecting the levels of over 87% of all metabolites detected. Many metabolic pathways that are critical for host physiology were affected, including bile acid, eicosanoid, and steroid hormone synthesis. Dissecting the molecular mechanisms involved in the impact of beneficial microbes on some of these pathways will be instrumental in understanding the interplay between the host and its complex resident microbiota and may aid in the design of new therapeutic strategies that target these interactions.

Citing Articles

Fecal tryptophan metabolite profiling in newborns in relation to microbiota and antibiotic treatment.

Aust A, Vidova V, Coufalikova K, Smetanova S, Kozeluhova K, Micenkova L Appl Microbiol Biotechnol. 2024; 108(1):504.

PMID: 39500766 PMC: 11538234. DOI: 10.1007/s00253-024-13339-4.


Metabolic immaturity and breastmilk bile acid metabolites are central determinants of heightened newborn vulnerability to norovirus diarrhea.

Peiper A, Morales Aparicio J, Hu Z, Phophi L, Helm E, Rubinstein R Cell Host Microbe. 2024; 32(9):1488-1501.e5.

PMID: 39214086 PMC: 11392616. DOI: 10.1016/j.chom.2024.08.003.


Probiotics and Antibiotic-Induced Microbial Aberrations in Children: A Secondary Analysis of a Randomized Clinical Trial.

Dierikx T, Malinowska A, Lukasik J, Besseling-van der Vaart I, Belzer C, Szajewska H JAMA Netw Open. 2024; 7(7):e2418129.

PMID: 38967929 PMC: 11227081. DOI: 10.1001/jamanetworkopen.2024.18129.


Potential Probiotic Weizmannia coagulans WC10 Improved Antibiotic-Associated Diarrhea in Mice by Regulating the Gut Microbiota and Metabolic Homeostasis.

Wang Z, Guo Z, Liu L, Ren D, Zu H, Li B Probiotics Antimicrob Proteins. 2024; .

PMID: 38900235 DOI: 10.1007/s12602-024-10308-1.


Applied physiology: gut microbiota and antimicrobial therapy.

Suslov A, Panas A, Sinelnikov M, Maslennikov R, Trishina A, Zharikova T Eur J Appl Physiol. 2024; 124(6):1631-1643.

PMID: 38683402 DOI: 10.1007/s00421-024-05496-1.


References
1.
Frank D, Pace N . Gastrointestinal microbiology enters the metagenomics era. Curr Opin Gastroenterol. 2007; 24(1):4-10. DOI: 10.1097/MOG.0b013e3282f2b0e8. View

2.
Hooper L, Macpherson A . Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol. 2010; 10(3):159-69. DOI: 10.1038/nri2710. View

3.
Shimada K, Bricknell K, Finegold S . Deconjugation of bile acids by intestinal bacteria: review of literature and additional studies. J Infect Dis. 1969; 119(3):273-81. DOI: 10.1093/infdis/119.3.273. View

4.
Jansson J, Willing B, Lucio M, Fekete A, Dicksved J, Halfvarson J . Metabolomics reveals metabolic biomarkers of Crohn's disease. PLoS One. 2009; 4(7):e6386. PMC: 2713417. DOI: 10.1371/journal.pone.0006386. View

5.
Vinson G . The adrenal cortex and life. Mol Cell Endocrinol. 2008; 300(1-2):2-6. DOI: 10.1016/j.mce.2008.09.008. View